The public burden of shifting trends in population health remains uncertain. Sustained increases in obesity, diabetes, and other diseases could reduce life expectancy -with a concomitant decrease in the public sector's annuity burden -but these savings may be offset by worsening functional status which increases health care spending, reduces labor supply, and increases public assistance. Using a health microsimulation model, we quantify the competing public fi nance consequences of shifting trends in population health for medical care costs, labor supply, earnings, wealth, tax revenues, and government expenditures. We fi nd that the trends in obesity and smoking have different fi scal consequences and that, because of its more profound effects on morbidity and health care expenditures, obesity represents a larger immediate risk from a fi scal perspective. Uncertainty in residual mortality improvements represents by far the largest risk.
I. INTRODUCTION
O ver the past century, the United States has enjoyed unprecedented improvements in health and longevity. Recently though, the skies have darkened as a result of rising obesity and diabetes, and worsening functional status among younger cohorts (Mokdad et al., 2001; Lakdawalla, Goldman, and Shang, 2005) . Much has been made about the resulting poor health status of Americans compared to their counterparts in the rest of the developed world (Banks et al., 2006; Michaud, van Soest, and Andreyeva, 2007) . At the same time, however, rates of smoking have declined substantially, presumably to the benefi t of overall health. The net effect of these large and offsetting trends remains uncertain, as does the future health and longevity of Americans. For example, while Olshansky et al. (2005) predict that life expectancy may fall in the next decade due to increased obesity, others such as Manton, Gu, and Lamb (2006) argue that longstanding declines in old-age self-reported disability will continue into the future. Meanwhile, the precarious fi nancial position of the public sector, along with its mounting annuity and medical cost liabilities, raises the policy stakes around the uncertain trends in health and longevity.
The interplay among health, longevity, individual decision-making, and public programs is both complex and vitally important to policy. Therefore, we examine how emerging trends in health, along with possible scenarios for health improvement, are likely to affect future health, longevity, savings, retirement, and public-sector liabilities over the next 50 years. We base our investigation on the "Future Elderly Model," a microsimulation model that serves as an engine for modeling the dynamics of population health, longevity, medical spending, and labor force participation .
Our status-quo scenario assumes current trends in obesity, smoking and other health conditions continue based on the experience of younger cohorts. To gauge the sensitivity of these forecasts, we consider three alternative scenarios. In the fi rst, we are able to reverse the current obesity trends that have been observed since the 1980s -an optimistic scenario in part based on recent trends (Ogden et al., 2007) .
The second scenario is less optimistic. Smoking among future generations of elderly is kept constant at its 2004 level. Although the prevalence of smoking among adolescents declined strongly in the 1980s, it increased during the 1990s and has since decreased slightly, according to Nelson et al. (2008) . The fi nal scenario considers hypothetical changes in mortality trends over the next 50 years that have been highlighted recently (Olshansky et al., 2009) . In particular, we assume improvements in all-cause mortality by 2 percent annually, compared to the 0.77 percent annual reduction assumed by the Social Security Administration.
The paper is structured as follows: Section II describes current trends in health in the United States. Section III describes the model that is used to simulate the long-term economic consequences of these trends. Section IV uses the model to quantify the impacts of the scenarios described above, and Section V discusses the results.
II. H EALTH TRENDS IN THE UNITED STATES
The United States and other developed countries have experienced large gains in life expectancy over the last century. For example, life expectancy at birth increased from 61 years in 1933 to 78 years in 2004. 1 The fi rst 50 years of the 20th century were marked by a strong decline in infectious diseases which greatly decreased mortality rates, particularly for the young. In the second half of the century, medical technology has been a critical factor behind further improvements in life expectancy, by reducing mortality rates among older age groups. But over the last 30 years, chronic illnesses associated with more sedentary lifestyles have spread, somewhat mitigating those advances. These trends are particularly pronounced in the United States .
On the other hand, recent declines in the prevalence of smoking have improved public health. In addition, old-age disability generally declined during the 1980s and early 1990s (Manton, Gu, and Lamb, 2006) . Figure 1 by showing the prevalence of lifetime smoking, obesity, diabetes, and hypertension over the last 10 years among the elderly population. We use data from the 1997-2006 National Heath Interview Surveys (NHIS) and focus on the population older than 50. 2 From 1997-2006, the fraction of obese individuals (BMI above 30kg/m 2 ) rose from 23.2 percent to 31.8 percent. One study projects that continuation of this trend will, by 2050, lead to an obesity rate of 50 percent among Americans aged 45 to 64. This will substantially increase the risk of obesity-related conditions such as diabetes, hypertension, heart disease, and stroke (Ruhm, 2007) . For example, only 5.5 percent of Americans aged 45-64 had Type-2 diabetes in 1980, according to the Centers for Disease Control and Prevention. Since then, the prevalence of this disease has roughly doubled to10.2 percent in 2005.
The same fi gure makes clear that smoking continues to fall, and rates of cancer and cardiovascular disease along with it. As a consequence, future overall health trends remain uncertain, and will depend upon the interplay between favorable trends in smoking (and perhaps in elderly disability), and unfavorable trends in obesity. At a minimum, the mix of diseases affl icting the elderly population is likely to change over the next 20 years. The effects on life expectancy and disability could be substantial.
Another important unknown is the pace of medical and pharmaceutical innovation. Cutler, Deaton, and Lleras-Muney (2006) argue that innovation is the most plausible major source of mortality improvements over the last half-century. C utler (2004) examines cardiovascular diseases, the leading cause of death among men over this period, and concludes that medical advances explain two-thirds of the improvement in mortality over the last half-century, with the other one-third likely explained by the decrease in smoking among men. Lichtenberg (2003) provides evidence that a large part of the gain in life expectancy in recent decades could be attributed to pharmaceutical innovation.
III. M ICROSIMULATION MODEL OF HEALTH AND ECONOMIC DYNAMICS
The current epidemiological literature features several well-known and complementary approaches for measuring population health and projecting future disease burden and mortality, including Manton, Gu, and Lamb (2006) , Lee (2000) , and Hayward and Warner (2005) . Across these models, there is an underlying trade-off between the complexity of the data required and the broad applicability of the model. For instance, early life table approaches like those of Sullivan (1971) require only age-specifi c population data as well as corresponding disability rates at those same ages; these elements are all present in cross-sectional data. However, these straightforward data requirements come at a cost, as the Sullivan method appears too insensitive to large changes in disability and mortality, and may thus underestimate future trends in population health (Bonneux et al., 1994) . Multistate life table models and microsimulation models that exploit longitudinal data, however, can accommodate richer dynamics than Sullivan's method and thus provide more fl exibility in modeling the dynamic interplay between morbidity, disability, and mortality. Such dynamic models obtain population health trends as aggregates from individual stochastic processes underlying these outcomes.
On the other hand, current models of economic decisions in old-age either ignore or take a very narrow view of health, which is often reduced to a self-reported indicator of "good" or "bad" health (Rust and Phelan, 1997; French, 2005) . This constraint is typically imposed because of computational limitations, rather than the preferences of the analyst. Dynamic structural models of economic decisions make a more detailed treatment of health computationally prohibitive. Microsimulation economic models such as the Modeling Income in the Near Term Model (Toder, et al., 2002) and the Congressional Budget Offi ce Long-Term Model (O'Harra, Sabelhaus, and Simpson, 2004) either do not incorporate health or adopt a very narrow defi nition of it.
For our purposes, we use a model that considers the dynamic interplay between a large number of health outcomes as well as economic outcomes. The model is an extension of the Future Elderly Model (FEM) in Goldman et al. (2004) . The FEM is a reduced-form Markovian model that allows for unobserved heterogeneity and correlation across outcomes. In that sense, it is well-equipped to analyze the effect of health trends on public fi nancial liabilities, as it allows for complex interactions between multi-dimensional measures of health and economic outcomes. We briefl y outline the key features of the FEM in the remainder of this section; Goldman et al. (2010) provides a complete technical description of the model. 3 The FEM was developed to examine health and health care costs among the elderly Medicare population . The most recent versions now project these outcomes for all Americans aged 50 and older. The defi ning characteristic of the FEM is the modeling of real rather than synthetic cohorts, all of whom are followed at the individual level. This allows for more heterogeneity in behavior than would be allowed by a cell-based approach. Also, since the Health and Retirement Survey (HRS) interviews both respondent and spouse, we can link records to calculate household-level outcomes such as net income and Social Security retirement benefi ts, which depend on the outcomes of both spouses. The omission of the population younger than age 50 sacrifi ces little generality, since the bulk of expenditure on the public programs we consider occurs after age 50. The model has three core components:
1. The initial cohort module predicts the fi nancial and health outcomes of new cohorts of 50 year-olds. This module uses data from the HRS and trends calculated from other sources. It allows us to "generate" cohorts as the simulation proceeds, so that we can measure outcomes for the age 50+ population in any given year.
2. The transition module calculates the probabilities of transitioning across various health states and fi nancial outcomes. The module inputs are risk factors such as smoking, weight, age and education, along with lagged health and fi nancial states. This allows for a great deal of heterogeneity and fairly general feedback effects. The transition probabilities are estimated from the longitudinal data in the HRS.
3. The policy outcomes module aggregates projections about individual-level outcomes into policy outcomes such as taxes, medical care costs, pension benefi ts paid, and disability benefi ts. This component takes account of public and private program rules to the extent allowed by the available outcomes. Because we have access to HRS-linked restricted data from Social Security records and employer pension plans, we are able to model retirement benefi ts realistically.
Operationally, we start in 2004 with an initial population aged 50+ taken from the HRS. We then predict outcomes using our estimated transition probabilities. Those who survive make it to the end of that year, at which point we calculate policy outcomes for the year. We then move to the following year, when a new cohort of 50-year olds enters. The entrants form the new age 50+ population that proceeds through the transition model as before. This process is repeated until we reach the fi nal year of the simulation.
A. Health of Future 50-Year Olds
Since we aim to characterize outcomes for the age 50+ population, we need to predict the characteristics of the 50-year-old population in terms of health, demographics and economic outcomes. The HRS does not include respondents younger than age 50; therefore, the characteristics of "future" 50-year olds must be modeled and imputed from data on younger individuals.
We estimate trends in the health of 50-year olds using two methods. We use the method described in Goldman et al. (2004) to calculate trends in disease prevalence from the NHIS. For outcomes other than disease prevalence, we use existing estimates, all of which are documented in Goldman et al. (2010) . In Figure 2 , the black lines represent our status-quo projection for smoking and obesity.
Second, we use the 50-year-old HRS respondents from 2004 as a template for future cohorts of 50 year olds. We "adjust" their health to match projected prevalence levels, using the trends estimated in the fi rst step. For example, if obesity is projected to go up in 2020, we increase the rate of obesity within the cohort of 50 year olds, by "reassigning" enough non-obese individuals to obesity status. Since obesity is correlated with other outcomes such as hypertension and diabetes, we reassign obesity status so that those at greatest risk are more likely to acquire it.
The reassignment is governed by a latent health model with correlated unobservables. An individual's disease status is a function of the mean population probability of the disease, along with a random error term. For an individual, the error terms are correlated across diseases. This builds in the possibility that, for instance, the occurrence of diabetes and hypertension are correlated. We jointly estimate the population means and the covariance structure of the error terms by maximum simulated likelihood. There are seven binary outcomes: hypertension, heart disease, diabetes, fair or poor self-reported health, labor force participation, insurance status and positive wealth. (The inclusion of this last indicator is necessary because of the observed spike in the distribution of net wealth at zero in the HRS.) There are three ordered outcomes: BMI status, smoking status, and functional status, defi ned as it is in the transition model. There are fi ve continuous outcomes: average indexed monthly earnings (AIME), the number of quarters of coverage, earnings, fi nancial wealth, and defi ned contribution (DC) wealth. We also model respondents' pension plan characteristics including whether they have a defi ned benefi t (DB) or DC plan at their current job, the earliest age at which they are eligible, and the normal retirement age. We group the latter around peaks in the empirical distribution. The most common early retirement age is 55, and the most common normal retirement age is 62. Each of these outcomes depends on fi xed characteristics such as race, education, gender and marital status. We also consider cancer, lung disease and stroke as fi xed, because their prevalence is very low in this population (age 50-53). Finally, the size of the entering cohort is adjusted to refl ect population projections from the Census by gender and race. We also adjust the size of the initial new cohort in 2004 to Census estimates by gender, race and ethnicity.
B. Transition Model
The transition model tracks movement among states as a function of risk and demographic factors. Goldman et al. (2010) provides details on the parametric structure, estimation, and validation of the model. In this paper we enumerate and discuss all the key inputs and outputs of the model, and how they are measured.
The data come from the 1992-2004 biennial waves of the HRS. We consider both health and economic outcomes: diseases, risk factors, functional status, labor force and benefi t status, fi nancial resources, nursing home residence, and death. At a particular point in an individual's life, the inputs into the model includes the individual's risk factors, along with their lagged disease status, functional status, labor force and benefi t status, fi nancial resources, and nursing home status. The outputs are current disease status, functional status, labor force and benefi t status, fi nancial resources, and nursing home status. More detail on variable measurement is presented below.
Transition rates are allowed to differ across demographic and economic groups. In particular, we allow differences by gender, race and ethnicity, education, and marital status. Transition equations are estimated on seven waves of the HRS. To assess the fi t, we use estimated transition probabilities to simulate what 1992 HRS respondents would look like in 2004. We then compare these to actual outcomes. We use half the sample for estimation and the other half for simulation. In general, the model fi ts the data quite well, with a close correspondence between predicted and actual outcomes in most areas, including labor supply, claiming behavior, functional status, and diseases. Complete results can be found in Goldman et al. (2010) .
C. Model Outcomes
The list of diseases includes the most prevalent conditions in the HRS survey: hypertension, stroke, heart disease, lung disease, diabetes, and cancer. An individual's disease status is estimated using the responses to questions of the form: "Has a doctor ever told you that you had…." Consistent with the chronic nature of these illnesses, we assume there is no chance of recovery and model the time until diagnosis (after age 50).
Second, we consider risk factors, focusing particularly on smoking and obesity. We model transitions across three "obesity" states: not obese (BMI<25), overweight (25-30), and obese (BMI>30). This information is derived from self-reported data on weight and height. 4 For smoking, we model whether the respondent has never smoked, has ever smoked but quit, or is still smoking at the time of the interview.
Third, we consider measures of functional status commonly known as activities of daily living (ADL) limitations and instrumental activities of daily living (IADL) limitations. These are counts of positive answers to questions (5 for ADL limitations and 7 for IADL limitations), such as whether the respondent has trouble walking, getting out of bed, dressing, etc. IADL limitations are typically less severe impairments than ADL limitations. We measure functional status by classifying respondents into the following categories: no IADL or ADL limitations, 1-2 IADL limitations but no ADL limitations, 1-2 ADL limitations, or 3+ ADL limitations. This classifi cation scheme yields four mutually exclusive categories (based on the data). These are not assumed to be absorbing states in that we allow for recovery.
Next, we add labor force and benefi t receipt outcomes. (We express all monetary units in terms of 2009 dollars using the Consumer Price Index.) First, we track whether someone works for pay (any positive hours), and we track earnings on the main job. We also track whether the respondent has employer-based health insurance, or derives coverage from other sources (apart from Medicare). We do this for the population younger than age 65. After age 65, nearly all respondents have insurance through Medicare. An individual can derive coverage through his employer, the employer of his or her spouse, a private insurer, or a government assistance program such as Medicaid (if disabled). We also record whether someone has a pension at work, and whether it is a DB or DC plan. If the respondent reports a DC pension, we also consider the self-reported account balance as another dependent variable. If the respondent reports a DB pension, we record the earliest age at which the pension can be claimed, as well as the number of years on the job and the normal retirement age on that plan. This information, combined with whether the person left a job with a DB pension, is used to construct an indicator for DB entitlement. Hence, we have two binary state variables (DC and DB entitlement) and one continuous state-variable (DC account balance) to account for a private pensions.
We model Social Security retirement benefi t receipt using the self-reported age at which benefi ts were fi rst claimed. Since we have access to earnings records for respondents in the HRS, we also determine who is eligible upon reaching age 62 using quarters of coverage. We construct the AIME for the initial interview and update the AIME in the simulation using a simplifi ed rule as utilized in French (2005) . 5 The AIME is the basis for computing benefi ts. We also model disability insurance (DI) benefi t receipt and Supplemental Security Income (SSI) using self-reports from the HRS. When reporting SSI fi gures however, we use a measurement error correction model estimated from merging self-reports with administrative data from SSA to correct for underreporting as described in Goldman et al. (2010) .
We then add measures of fi nancial resources. We construct a measure of net fi nancial wealth using self-reports from the HRS (Hoynes, Hurd, and Chand, 1998) . Net fi nancial wealth is defi ned as the value of fi nancial assets (checking, savings, stocks, IRAs, certifi cate of deposits, bonds) plus the value of real assets (primary house, other real estate, other real assets) minus all debt (mortgage, home loans, credit cards, etc). We also track earnings, and whether wealth is positive. To account for the skewness of the wealth and earnings distribution, we use the generalized inverse hyperbolic sine transformation (MacKinnon and Magee, 1990) . For both wealth and earnings, we censor observations above the 99 th percentile in 2004.
Finally, we track nursing home residence and mortality. The HRS initially did not sample from the nursing home population. However, it does follow respondents into nursing homes and also records transition back to independent or assisted living outside nursing homes. Mortality is recorded in exit interviews in the HRS. Mortality hazards derived from the HRS correspond closely with life-table probabilities (Adams et al., 2003; Kapteyn et al., 2006) . In our projections, we assume the same mortality rate reduction as in the 2007 OASDI Trustees Report (averaging 0.77 percent reduction per year).
In addition to the individual outcomes, the model predicts revenues and expenditures by the federal government for the age 50+ population. Next, we compute Social Security retirement benefi ts for those predicted to receive such benefi ts. Since we have the AIME of both respondent and spouse, we can precisely estimate the distribution of retirement benefi ts. We account for spouse and survivor benefi ts. We also compute DI benefi ts and SSI. We compute DB pension income from average pension payments by tenure, last year of earnings and early and normal retirement ages using pension plan characteristics reported by employers of HRS respondents. Using all these income fl ows, for the respondent and the spouse (if present), we compute net household income including federal, state, and city income taxes as well as the payroll taxes (OASDI and Medicare).
IV. SCENARIOS AND RESULTS
We estimate three scenarios for population health:
1. Obesity Scenario: Among 51-52 year olds, the prevalence of obesity, hypertension and diabetes are rolled back to 1978 levels (obesity was 13.9 percent) by 2030 and then held constant until 2050. In the simulation, incoming cohorts exhibit gradually lower obesity until 1978 levels are fi nally reached in the year 2030;
2.
Smoking Scenario: Among 51-52 year olds, the prevalence of current smokers is held constant at the 2004 level;
3. Mortality reduction scenario: Among 51-52 year olds, our model incorporates faster annual declines in mortality, from 0.77 percent annually to 2 percent annually by 2030. 6 Figure 2 presents the prevalence rates we use under different scenarios for the incoming cohorts. Each of these scenarios is compared to our status-quo scenario, which projects future trends under the assumption that current trends are allowed to persist. Table 1 presents detailed results under the status quo. Given current trends, we project the size of the population aged 50+ will increase by nearly 84 percent, from 80.8 million in 2004 to 148.3 million in 2050. As shown in Figure 3 , this refl ects the impact of population aging and of an increase in life expectancy at age 50, which increases from 30.6 years in 2004 to 34.3 years in 2050. Figure 3 also shows that the increase in the number of years of healthy living (without any limitations in activities of daily living) would be much smaller, increasing from 25.2 years in 2004 to 26 years in 2050. In other words, the increase in life expectancy comes disproportionately from longer time spent disabled or in an unhealthy state. This length of time spent disabled increased by 2.8 years over the period. The prevalence of obesity among individuals 50+ is projected to increase from 28.1 percent in 2004 to 46.5 percent in 2050. As a result, the prevalence of diabetes, hypertension, and heart disease are also projected to increase. In 2050, 28.7 percent of Americans are projected to have diabetes and nearly two-thirds are projected to have hypertension.
Two percent was considered as a plausible scenario by the 2007 Technical Panel on Assumptions and
Methods conveyed by the SSA. Regarding the current assumptions used in the Trustee report they note on page 29 of their report: "The ultimate rates of mortality decline for the high-cost projection, however, should be increased substantially to 2.00 percent to refl ect intrinsic uncertainty inherent in projections based solely on experience data from the U.S., as well as additional uncertainty arising from the potential for the U.S. to reach rates of mortality decline seen in international data for 33 high-income countries with higher life expectancies." Hence, although this scenario requires a rapid pace of medical innovation over the next 20 years, it represents a useful scenario to place a bound on mortality improvements from innovation.
Hence, our results do not reveal a compression of morbidity as suggested in Manton, Gu, and Lamb (2006) . One way to generate a compression of morbidity would be to assume improvements in avoiding disability, conditional on disease diagnosis.
As noted in Goldman et al. (2010) , our population forecasts for the age 65+ population in 2050 is very similar to that of the Social Security Administration (80.8 million versus 81.6 million, respectively) and much lower than Census projections (86.7 
Figure 3
Baseline Projection of Life-Expectancy at age 50 million), which assume larger reductions in mortality. Since the smoking and obesity trends represent the major differences between our model and that of the Social Security Administration, this fi nding is consistent with the view that smoking and obesity trends offset each other. Repeating the simulation, but holding health status constant, yields a population forecast for 2050 of 79.5 million. This suggests that health trends generate a small positive effect on life expectancy.
Government revenues are projected to increase from 2004 to 2050, primarily due to population growth, as are government entitlement expenditures. For example, Medicare costs are projected to be more than 4.4 times higher in 2050 than in 2004 ($1.477 trillion in 2050) while OASI expenditures are projected to be 3.6 times higher ($1.629 trillion in 2050). Perhaps more importantly, the results from the status-quo scenario make clear the rapidly increasing fi nancial burden on a shrinking workforce. To isolate the role played by trends in health, we now look at a number of counterfactual scenarios.
A. Obesity Scenario
The obesity scenario rolls back the prevalence of obesity among 50-year olds to its 1978 level by 2030, where it remains until 2050. As shown in Table 2 , this will decrease the prevalence of obesity among the age 50+ population in 2050 from 46.5 percent to 23.7 percent, representing almost a 50 percent decline. We also simulate a decrease in the prevalence of associated health conditions. For example, the prevalence of diabetes drops from 28.7 percent in the status-quo to 18.2 percent by 2050. As a result, the size of the age 65+ population in 2050 is projected to rise by roughly 2.6 million. This is due to an increase in life expectancy of entering cohorts as shown in Figure 4 . The remaining life expectancy of age 50 entrants in 2050 rises by 1.3 years relative to the status-quo. The increase in life expectancy also brings about a roughly half-year decrease in the expected number of years living with a disability. These provide important health benefi ts to cohorts alive in these years. Disabled (1+ ADLs)
Figure 4
Life Expectancy Diff erences at Age 50 in Three Scenarios (2050 Cohort) In 2050, the obesity reduction scenario implies a 3.4 percent reduction in Medicare costs, due largely to the better health of the population. Medicaid savings are even larger, 6.8 percent, due to the higher prevalence of obesity and smoking in the Medicaid population. Revenues also increase slightly, by $10 billion or 1.7 percent, due in part to longevity and labor force participation effects. On the other hand, OASI benefi ts increase by 2.3 percent when we reduce obesity, because of the associated increase in longevity. This offsets part of the Medicare and Medicaid savings and revenue increase.
To grasp the importance of these differences, we compute the present value of the gains and losses for each group of expenditures and revenues from 2004-2050. We use a 3 percent real discount rate. This provides a measure of the actuarial fi scal surplus we would experience if we followed this scenario. We present these estimates in Figure 5 . The present value of all Medicare and Medicaid savings under the obesity scenario are $252.0 billion and $265.2 billion, respectively. The present value of future additional Social Security benefi t outlays is $139.5 billion. The costs to Social Security are smaller than the benefi ts to Medicare in part because they occur farther in the future. As new, healthier (and lighter) cohorts enter the model, the disability reduction benefi ting Medicare takes place before the increase in longevity, which increases Social Security benefi ts. 
Figure 5
Eff ect of Obesity Scenario on Present Discounted Value of Government Revenues and Expenditures
Rolling back obesity increases revenues by $70.5 billion (this includes federal, OASI and Medicare taxes). When added to the expenditure savings, the total net effect of the reduction in obesity on public fi nances is $467 billion in savings. Our analysis suggests that the health benefi ts of lower obesity occur earlier than the (public fi nance) costs of greater longevity. In terms of magnitudes, $350.7 billion represents the total discounted revenue from Medicare payroll taxes from 2004-2030, which is a sizeable surplus.
B. Smoking Scenario
We now turn our attention to shifts in the prevalence of smoking. Under the status-quo scenario, the prevalence of smoking (ever smoked and currently smoking) is projected to decline. The scenario, on the other hand, keeps the prevalence of current smoking among 50-54 year olds at its 2004 level. The extent of the change in prevalence is shown in Figure 2 (middle panel). Table 3 reports detailed results from this simulation. The size of the age 65+ population in 2050 is 1.8 million smaller under this scenario. However, as shown in the table, the decrease in the age 65+ population occurs mostly after 2030; the timing is driven by the long delayed effect of smoking on longevity. Figure 4 shows that life expectancy at age 50 in the smoking scenario is 1.3 years lower than under the status-quo in 2050. This translates into cost savings for OASI and very little increase in costs for Medicare and Medicaid. The reduction in the size of the elderly population offsets the other health effects. Greater mortality costs the government a 1.9 percent decline in revenues in 2050, or $11.5 billion. Hence, while expenditures decrease, so do revenues. Figure 6 shows the effect of the smoking scenario on the present value of various government expenditures. Hence, unlike the obesity scenarios, this scenario yields modest effects on government expenditures, but large effects on life expectancy. The longevity effect largely offsets the increase in disability and the modest increase in health care costs. 7 On the revenue side, there is a large negative effect on revenues (-$63.9 billion), largely on Federal tax revenue. Overall, the net present value of fi scal liabilities increases by $72.5 billion with this worsening of the health of older Americans. This is about eight times smaller than the net public sector effect of the obesity scenario. Hence, uncertainty in the trend for smoking does not appear to have large fi scal consequences over that period.
C. Mortality Reduction Scenario
The last scenario consists of assuming larger mortality improvements over the next 50 years. Following the suggestion from the 2007 OASDI Trustees Report from the technical panel on assumptions and methods, we assume convergence by 2030 to a 2 percent annual decline in mortality. This implies a doubling in the annual rate of decrease, relative to status quo projections. Figure 4 shows that this increases life expectancy by 6.7 years for the cohort entering in 2050. A little more than two-thirds of that increase comes from extending life with a disability (4.7 years increase). Table  4 shows that this has a large effect on the size of the population alive in 2050. In 2050, population age 65+ is 13.1 million larger than in the status quo simulation. This has the effect of increasing expenditures, mostly concentrated among the old, while only marginally affecting revenues, of which 90 percent is derived from those younger than 65. Hence, the mortality reduction scenario has the effect of increasing net expenditures by a substantial amount for the older population, but with little immediate benefi t in the younger population. In terms of present net value over the period 2004-2050, Figure  7 shows that the present value of Social Security benefi ts is nearly $1.3 trillion larger over the period 2004-2050. This is about half the combined effect on Medicare and Medicaid ($1.1 and $1.01 trillion respectively). Since revenues are marginally affected, the net actuarial liability imposed by this scenario is $3.47 trillion. 
Figure 6
Eff ect o f Smoking Scenario on the Present Discounted Value of Government Revenues and Expenditures (2004-2050) 
V. DISCUSSION
In this paper, we use a health microsimulation model, with economic outcomes, to study the public fi nance consequences of trends in health. It is well understood that better health leads to cost-savings for public health insurance, but greater liabilities for public annuities. However, the timing and duration of mortality and morbidity changes are of crucial importance. By defi nition, medical cost savings accrue earlier in life than increases in annuity burden. This helps explain why the rising rate of obesity leads to greater public liabilities, a result that is aided further by the modest longevity reductions associated with obesity. However, this tendency may not be enough if -as in the case of smoking reduction -the period of reduced morbidity is relatively short and close to the end of life.
There is a popular perception that government programs benefi t from worsened health. This perception is typically formed from the case of smoking, in which longevity reductions do in fact benefi t a number of government programs. However, it does not hold universally. For example, lowering obesity would save Medicare and Medicaid more 
Figure 7
Eff ect of Mortality Reduction Scenario on the Present Discounted Value of Government Expenditures than it would cost in terms of public annuity obligations. Public health interventions in these areas, therefore, could produce very large gross returns for the public purse. Uncertainty due to the residual component of mortality improvements appears to have important fi scal consequences. Perhaps more than health trends, the pace of medical and pharmaceutical innovation is likely to be one of the main drivers of future expenditures and revenues. If the annual rate of decrease in mortality speeds up to 2 percent, it would have dramatic effects on our fi scal future.
To be clear, our study is not designed to calculate the total social welfare effects of changing public health trends or mortality, but rather to isolate the fi scal effects, which are of independent interest to policymakers. As such, we cannot justifi ably advocate increases in smoking, or even reductions in obesity, upon the basis of these results alone. However, our work demonstrates that the fi scal effects of these two major health trends, in particular obesity, are large enough to become part of the social welfare calculus for evaluating changes in these two health behaviors as well as improvements in life expectancy.
